Replies to post #119326 on Biotech Values

[DewDiligence]

RBXY is seeking payment from other generic-drug companies to waive its 180-day exclusivity on generic Lipitor, according to analysts cited by Bloomberg:

http://www.bloomberg.com/news/2011-08-18/lipitor-generic-rights-may-be-sold-should-ranbaxy-s-approval-come-too-late.html